Nomi (YC X25)

Executive Summary

Nomi (YC X25) is a pre-seed, 2-10 person startup building a real-time AI sales copilot — it listens to live Zoom/Meet calls and surfaces phrase suggestions to help reps close deals. The YC backing and product launch are real and verified, but traction is essentially zero by institutional standards: no confirmed paying customer count, no audited revenue, and a single unverified self-reported $330K ARR figure from a domain that doesn't even match the company's known URL. The competitive landscape is brutal — Gong ($7.25B, $200M+ ARR), Clari/Wingman, Outreach Kaia, and Salesloft all compete in the same lane with massive data and distribution advantages. The single biggest complication for this report is a severe data disambiguation problem: the research corpus pulled extensive, deeply damaging material on Nomi Health (software copyright infringement judgment, $7M+ in damages, federal copyright case pending) and Nomi AI (documented chatbot suicide instruction incident, FTC inquiry, product safety failures) — none of which applies to the YC X25 sales copilot, but which creates meaningful brand and investor perception risk that the founding team must actively manage.